Home About_Us Development Experience Press Releases Contact

Thesis Chemistry Inc.

Contact @ Thesis Chemistry Inc.
Donald Straw, President and COO
Phone: +1 905 273 7251
Web: www.thesischemistry.com
Major Chemicals Co., Ltd

Contact @ Major Chemicals Co., Ltd
Yan Jie, Pharmacist
Phone: +86 571 88388397
Web: www.majorchemicals.com


NEWS RELEASE

THESIS CHEMISTRY TO MARKET PHARMACEUTICAL RAW MATERIALS AND PRODUCTS AND ACCESS CHINESE CUSTOM MANUFACTURING RESOURCES

MISSISSAUGA, ONTARIO and HANGZHOU, CHINA—November 5, 2002—Thesis Chemistry Inc., a provider of innovative Chemistry, Manufacturing and Control (CMC) development services to the pharmaceutical industry, announces a strategic marketing agreement with Major Chemicals Co., Ltd. Under the agreement, Thesis Chemistry will represent and market Major Chemicals' pharmaceutical raw materials, intermediates and generic drug substances to the North American pharmaceutical, animal health and generic drug industries. In addition, Major Chemicals will provide Thesis Chemistry with access to Chinese custom manufacturing resources for the commercial production of pharmaceutical intermediates and generic drug substances.

"Our alliance with Major Chemicals is vital to Thesis Chemistry's mission of delivering integrated and innovative CMC development capabilities to our customers," says Dr. John R. Peterson, Chairman and Chief Executive Officer of Thesis Chemistry. "The industry is continually seeking ways to reduce manufacturing costs. Through this alliance, we can provide our customers with a reliable supply of high quality, low-cost raw materials and early process intermediates, which in turn favorably drives production economics."

Thesis Chemistry powers pharmaceutical research and development through creative chemistry. Founded in 2002 as a private Canadian corporation, the Company manages and offers the highest-quality technical capabilities in support of CMC development of small-molecule drugs. Through core expertise in process and analytical chemistry and familiarity with the current regulatory requirements of drug development, Thesis Chemistry significantly reduces the time and cost of chemical development, while delivering innovative process solutions for the economical commercial manufacture of Active Pharmaceutical Ingredients (APIs). By linking specialized processing technologies and capabilities available through a network of industry partners, Thesis Chemistry brings the right technology and development capability to a project at the right time. Thesis Chemistry supports CMC development with supplies of pre-clinical and clinical API's, process design, development and optimization, analytical testing and stability, commercial API manufacture and the identification of reliable and low-cost sources of raw materials and process intermediates.

Major Chemicals is a leading supplier of Chinese pharmaceutical raw materials, intermediates, herbal extracts and many other chemical products to the global pharmaceutical, generic drug and fine chemical industries. Major Chemicals provides these industries with a reliable and economical source of over 500 chemicals, intermediates and drug substances by managing the production and export in the Peoples Republic of China.